Search Results - "Reist, C."

Refine Results
  1. 1

    Radioiodination via D-amino acid peptide enhances cellular retention and tumor xenograft targeting of an internalizing anti-epidermal growth factor receptor variant III monoclonal antibody by FOULON, C. F, REIST, C. J, BIGNER, D. D, ZALUTSKY, M. R

    Published in Cancer research (Chicago, Ill.) (15-08-2000)
    “…The mutant epidermal growth factor receptor variant III (EGFRvIII) has been found on gliomas and other tumors but not on normal tissues, including those that…”
    Get full text
    Journal Article
  2. 2

    Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas by WIKSTRAND, C. J, HALE, L. P, TRAWEEK, S. T, WONG, A. J, ZALUTSKY, M. R, BIGNER, D. D, BATRA, S. K, HILL, M. L, HUMPHREY, P. A, KURPAD, S. N, MCLENDON, R. E, MOSCATELLO, D, PEGRAM, C. N, REIST, C. J

    Published in Cancer research (Chicago, Ill.) (15-07-1995)
    “…Despite molecular biological advances in understanding human cancers, translation into therapy has been less forthcoming; targeting neoplastic cells still…”
    Get full text
    Journal Article
  3. 3

    Organization and results of student pharmacist bone mineral density screenings in women by Harris, Adam C., PharmD, Doucette, William R., PhD, Reist, Jeffery C., PharmD, Nelson, Kathryn E., PharmD

    “…Objective To describe the organization and results of student pharmacist–run screenings of bone mineral density (BMD) among women living in the community…”
    Get full text
    Journal Article
  4. 4

    Barriers to Increasing Prescription Drug Monitoring Program Use: A Multidisciplinary Perspective by St. Marie, Barbara J., Witry, Matthew J., Reist, Jeffrey C.

    Published in Computers, informatics, nursing (01-08-2023)
    “…Prescription drug monitoring programs are implemented through individual state policies and are one solution to curb the opioid crisis. The objectives of this…”
    Get full text
    Journal Article
  5. 5

    The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target by Wikstrand, C J, Reist, C J, Archer, G E, Zalutsky, M R, Bigner, D D

    Published in Journal of neurovirology (1998)
    “…Any immunotherapeutic approach to cancer cell eradication is based upon the specific recognition of neoplastic cells and the sparing of surrounding normal…”
    Get more information
    Journal Article
  6. 6
  7. 7

    An Exploratory Mixed Methods Study of Standardized Patient Comments on Empathy and Student Communication Scores by Murry, Logan T., Reist, Jeffrey C., Fravel, Michelle A., Knockel, Laura E., Witry, Mathew J.

    “…Objective. To quantify student pharmacists’ communication ability based on scores from standardized patient (SP) communication rubrics, describe and categorize…”
    Get full text
    Journal Article
  8. 8

    Incorporation of an Efficient Pharmacist Workflow During the Transition From In-Person to Telemedicine Geriatric Clinics in Response to the COVID-19 Pandemic by Reist, Jeffrey C., Zahn, Brent, Oche, Onyeche, Shannon, Zacariah K., Casteel, Carri, Dobyns, Richard C., Kennelty, Korey A.

    Published in Journal of pharmacy practice (01-12-2023)
    “…The COVID-19 pandemic created care continuity challenges for older adults in the ambulatory care setting. Similarly, maintaining the multidisciplinary team…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Altered Sleep Duration and Poor Quality of Sleep Among Pharmacy Students Amidst COVID-19 Lockdown: A South-Indian Study by Bhat, P. Vaidehi, George, Sophia M., Chand, Sharad, Kurian, Kauma, Roy, Emy Susan, Mathew, Greeshma, Prajnashree, R., Nath, Haritha S., Babu, Akshara Theresa, Reist, Jeffrey C.

    Published in Sleep and vigilance (01-06-2022)
    “…Introduction/background The nationwide lockdown enforced due to the spread of coronavirus disease-2019 had a definite impact on sleep. Objective To observe any…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Astatine-211 labeling of internalizing anti-EGFRvIII monoclonal antibody using N-succinimidyl 5-[ 211At]astato-3-pyridinecarboxylate by Reist, Craig J, Foulon, Catherine F, Alston, Kevin, Bigner, Darell D, Zalutsky, Michael R

    Published in Nuclear medicine and biology (01-05-1999)
    “…Monoclonal antibodies (MAbs) such as the anti-epidermal growth factor variant III (EGFRvIII) MAb L8A4 are rapidly internalized, which can lead to rapid loss of…”
    Get full text
    Journal Article
  13. 13

    Radioiodination of internalizing monoclonal antibodies using N-succinimidyl 5-iodo-3-pyridinecarboxylate by REIST, C. J, GARG, P. K, ALSTON, K. L, BIGNER, D. D, ZALUTSKY, M. R

    Published in Cancer research (Chicago, Ill.) (01-11-1996)
    “…Monoclonal antibodies (mAbs) that internalize following binding to cell-surface receptors require radiolabeling approaches that minimize loss of radioactivity…”
    Get full text
    Journal Article
  14. 14

    Improved targeting of an anti-epidermal growth factor receptor variant III monoclonal antibody in tumor xenografts after labeling using N-succinimidyl 5-iodo-3-pyridinecarboxylate by REIST, C. J, ARCHER, G. E, WIKSTRAND, C. J, BIGNER, D. D, ZALUTSKY, M. R

    Published in Cancer research (Chicago, Ill.) (15-04-1997)
    “…Monoclonal antibody (mAb) L8A4, specific for the tumor-associated mutant epidermal growth factor receptor variant III (EGFRvII), is internalized and degraded…”
    Get full text
    Journal Article
  15. 15

    Development and operation of an improved turntable dust feeder by Reist, Parker C, Taylor, Lauralynn

    Published in Powder technology (01-01-2000)
    “…An improved version of a dry dispersion turntable aerosol feeder has been developed which provides greater variation, control, and reliability in aerosol…”
    Get full text
    Journal Article
  16. 16

    Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease by Hiatt, William R, Fowkes, F. Gerry R, Heizer, Gretchen, Berger, Jeffrey S, Baumgartner, Iris, Held, Peter, Katona, Brian G, Mahaffey, Kenneth W, Norgren, Lars, Jones, W. Schuyler, Blomster, Juuso, Millegård, Marcus, Reist, Craig, Patel, Manesh R

    Published in The New England journal of medicine (05-01-2017)
    “…In this randomized trial involving 13,885 patients with symptomatic peripheral artery disease (PAD), ticagrelor was not shown to be superior to clopidogrel for…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Human IgG2 constant region enhances in vivo stability of anti-tenascin antibody 81C6 compared with its murine parent by REIST, C. J, BIGNER, D. D, ZALUTSKY, M. R

    Published in Clinical cancer research (01-10-1998)
    “…The in vivo properties of radiolabeled chimeric monoclonal antibodies (mAbs) with human IgG1 and IgG3 constant regions generally are similar to those of their…”
    Get full text
    Journal Article